Nasal spray of stem cell 'Messages' could slow rare brain disease
NCT ID NCT07638813
First seen Jun 27, 2026 · Last updated Jul 14, 2026 · Updated 2 times
Summary
This study tests a new nasal spray treatment for frontotemporal dementia (FTD), a brain disease that changes personality and language. The spray contains tiny particles from umbilical cord stem cells that may protect brain cells and reduce harmful protein buildup. About 33 adults with FTD will receive either the spray or a placebo to see if it is safe and can slow the disease. Currently, there is no cure for FTD, so this treatment aims to control the disease rather than eliminate it.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FRONTOTEMPORAL DEMENTIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a nudge in your chart unlock Life-Saving genetic clues?
- Could a brain disease change behavior years before diagnosis?
- Can a synthetic cannabinoid calm agitation in frontotemporal dementia?
- Can sound waves soothe Dementia's emotional turmoil?
- Brain scan tracer could reveal hidden signs of psychosis in Parkinson's
- Could tiny doses of radiation slow Alzheimer's? a new trial investigates